Question 1

What does the science actually say about Lion's Mane and cognition?

Accepted Answer

The most-cited human study is Mori 2009: a 16-week double-blind placebo-controlled RCT in 30 Japanese adults with mild cognitive impairment, taking 3 g/day Yamabushitake (Lion's Mane) fruiting body powder. The supplemented group showed significantly higher cognitive scores during weeks 8–16, with the effect attenuating after 4 weeks of withdrawal. This is a meaningful signal — but it is one small trial in a single specific population using a specific Japanese product. Other human trials are similarly small and short. The cognitive narrative for Lion's Mane is genuinely interesting but is overstated relative to the size of the evidence base. There is no large RCT in healthy adults.

Question 2

What's the difference between fruiting body and mycelium products?

Accepted Answer

The fruiting body is the visible mushroom and contains hericenones — the bioactives most strongly linked to NGF stimulation in cell studies. Mycelium is the root-like network grown on a substrate, typically grain (oats or rice), and contains erinacines — different bioactives also implicated in NGF synthesis. The catch is that mycelium-on-grain products are sold as the combined mass, and many UK products are dominated by leftover starch from the grain substrate rather than active mushroom material. For higher quality, choose fruiting body extracts, dual-extracted (water and alcohol) products, and look for declared beta-glucan content and certificates of analysis. Ignore vague 'mushroom blend' marketing.

Question 3

What dose has been studied?

Accepted Answer

Mori 2009 used 3 g/day of Yamabushitake fruiting body powder. Other small Japanese trials have used 0.5–3 g/day for 4–16 weeks. There is no established clinical dose for Lion's Mane — the supplement is dosed pragmatically based on the limited trial range. Effects, where reported, take 4+ weeks to emerge and decline after withdrawal. Higher-concentration extracts may achieve the same active dose at lower mg/day, which is why product specification (extract ratio, beta-glucan content, fruiting body vs mycelium) matters more than the headline dose.

Question 4

Is Lion's Mane safe?

Accepted Answer

Lion's Mane has a long history of dietary use as an edible mushroom and is generally well-tolerated. Reported adverse effects in trials are mild — occasional GI upset. The most important safety considerations are: (1) mushroom allergy is a contraindication; (2) allergic reactions including skin rash and breathing difficulty have been reported in case studies; (3) possible mild antiplatelet effect — caution with anticoagulants; (4) safety in pregnancy and breastfeeding has not been established. Quality is the bigger practical issue: many UK products contain minimal active material and are essentially expensive grain.

Question 5

Has EFSA authorised any claim for Lion's Mane?

Accepted Answer

No. EFSA has not authorised any specific health claim for Hericium erinaceus or Lion's Mane under EU/UK retained nutrition and health claims regulation. UK manufacturers cannot legally claim Lion's Mane improves cognition, memory, or treats any neurological condition. Marketing language tends to use phrases such as 'traditionally used' or describe the mushroom rather than make explicit health claims. Consumers should be aware that the absence of an authorised claim is the legal position, separate from the still-evolving science.

Question 6

Should I take Lion's Mane?

Accepted Answer

Honest framing: the evidence is preliminary but not nothing. There is a plausible mechanism (NGF stimulation in cell models), one positive RCT in MCI (Mori 2009), and small additional trials suggesting mood and anxiety effects. There is no large definitive trial in healthy adults, no replication outside Japan in the original population, and the marketing has run far ahead of the data. If you have a specific cognitive concern, prioritise sleep, exercise, blood pressure control, and getting NHS-recommended hearing and vision checks — the evidence base for those interventions dwarfs anything for Lion's Mane. As a low-risk experimental supplement at a sensible dose with a quality-verified product, it is reasonable, but framing it as a proven nootropic is not supported by current evidence.

Grade	Health Outcome	Studies	Participants	Effect
C	Cognitive Function in Mild Cognitive Impairment1 studies	1	30	Mori 2009 RCT (Yamabushitake fruiting body, 3 g/day for 16 weeks, n=30 Japanese adults with MCI) reported improved cognitive function scale scores during supplementation, with effect attenuating after withdrawal.
D	Anxiety and Mood Symptoms2 studies	2	60	Two small Japanese RCTs report modest reductions in self-reported anxiety and depression scores. Sample sizes are small, populations narrow, and replication is limited.
D	Nerve Growth Factor (Mechanism)0 studies	0	0	Hericenones (fruiting body) and erinacines (mycelium) stimulate nerve growth factor synthesis in cell and animal models. NGF stimulation has not been demonstrated in human plasma or cerebrospinal fluid in published trials.

Lion's Mane

Evidence Database

Supplier Directory

Myprotein

Bulk

Amazon UK

Holland & Barrett

Thorne

Cost Comparison

General Information

Dosage (Evidence-Reported)

Safety Notes

Key Benefits

Quick Facts

Frequently Asked Questions